New supplement shows promise for gut health in small trial
NCT ID NCT07215676
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This small pilot study tested an 8-week nutritional supplement in 9 adults with hydrogen-dominant SIBO. The main goal was to see if the supplement was safe and well-tolerated. Researchers also looked at whether symptoms and quality of life improved. There was no comparison group, so results are preliminary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL INTESTINAL BACTERIAL OVERGROWTH SYNDROME (SIBO) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NUNM - Helfgott Research Institute
Portland, Oregon, 97201, United States
Conditions
Explore the condition pages connected to this study.